The results will do the talking on this SP so if they are good it flies, if not, it dies... CEO...not as important as the results and effectiveness of the drug...but would help if marketed the potential better IMO
- Forums
- ASX - By Stock
- DXB
- sub analysis overdue
sub analysis overdue, page-85
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
37.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $209.1M |
Open | High | Low | Value | Volume |
38.0¢ | 38.5¢ | 36.5¢ | $579.4K | 1.548M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 91570 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 7922 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 91570 | 0.370 |
8 | 127960 | 0.365 |
13 | 301942 | 0.360 |
3 | 73000 | 0.355 |
7 | 165780 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 714 | 1 |
0.380 | 56816 | 4 |
0.390 | 17637 | 3 |
0.395 | 142800 | 4 |
0.400 | 277640 | 8 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online